MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Long non‑coding RNA DANCR aggravates breast cancer through the miR‑34c/E2F1 feedback loop
Long non‑coding RNA DANCR aggravates breast cancer through the miR‑34c/E2F1 feedback loop
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Long non‑coding RNA DANCR aggravates breast cancer through the miR‑34c/E2F1 feedback loop
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Long non‑coding RNA DANCR aggravates breast cancer through the miR‑34c/E2F1 feedback loop
Long non‑coding RNA DANCR aggravates breast cancer through the miR‑34c/E2F1 feedback loop

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Long non‑coding RNA DANCR aggravates breast cancer through the miR‑34c/E2F1 feedback loop
Long non‑coding RNA DANCR aggravates breast cancer through the miR‑34c/E2F1 feedback loop
Journal Article

Long non‑coding RNA DANCR aggravates breast cancer through the miR‑34c/E2F1 feedback loop

2024
Request Book From Autostore and Choose the Collection Method
Overview
Emerging scientific evidence has suggested that the long non-coding (lnc)RNA differentiation antagonizing non-protein coding RNA (DANCR) serves a significant role in human tumorigenesis and cancer progression; however, the precise mechanism of its function in breast cancer remains to be fully understood. Therefore, the objective of the present study was to manipulate DANCR expression in MCF7 and MDA-MB-231 cells using lentiviral vectors to knock down or overexpress DANCR. This manipulation, alongside the analysis of bioinformatics data, was performed to investigate the potential mechanism underlying the role of DANCR in cancer. The mRNA and/or protein expression levels of DANCR, miR-34c-5p and E2F transcription factor 1 (E2F1) were assessed using reverse transcription-quantitative PCR and western blotting, respectively. The interactions between these molecules were validated using chromatin immunoprecipitation and dual-luciferase reporter assays. Additionally, fluorescence in situ hybridization was used to confirm the subcellular localization of DANCR. Cell proliferation, migration and invasion were determined using 5-ethynyl-2′-deoxyuridine, wound healing and Transwell assays, respectively. The results of the present study demonstrated that DANCR had a regulatory role as a competing endogenous RNA and upregulated the expression of E2F1 by sequestering miR-34c-5p in breast cancer cells. Furthermore, E2F1 promoted DANCR transcription by binding to its promoter in breast cancer cells. Notably, the DANCR/miR-34c-5p/E2F1 feedback loop enhanced cell proliferation, migration and invasion in breast cancer cells. Thus, these findings suggested that targeting DANCR may potentially provide a promising future therapeutic strategy for breast cancer treatment.